Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
YU, Zongyang
NCT05675761: The Efficacy and Safety of Azovudine in the Treatment of COVID-19	Recruiting	N/A	500	RoW	Azorubine, basic treatment	Fuzhou General Hospital	COVID-19, Infections, Morality, Death, Assisted	10/24	10/24
NCT06775015: SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer	Not yet recruiting	N/A	200	RoW	Serum Raman spectroscopy intelligent diagnostic system	Fuzhou General Hospital	Lung Cancer Patients	12/26	12/26
SERS on lung, NCT06775587: SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules	Not yet recruiting	N/A	200	RoW	Serum Raman spectroscopy intelligent diagnostic system	Fuzhou General Hospital	Lung Cancer in Normal and Malignant Tumors	12/26	12/26
NCT06772363: SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis	Not yet recruiting	N/A	200	RoW	Serum Raman spectroscopy intelligent diagnostic system	Fuzhou General Hospital	Lung Cancers	06/26	06/26
NCT05677789: Defining COVID-19 Infection Severity on Presentation to Hospital	Recruiting	N/A	3000	RoW	Medical observation, Supportive treatment (BSC), Intensive care management	Fuzhou General Hospital	COVID-19, Infections, Morality, Death, Assisted	12/23	12/23
NCT05486988: ctDNA as a Biomarker for Treatment in Advanced NSCLC	Not yet recruiting	N/A	500	RoW	Immunotherapy, Chemotherapeutic Agent, Chemotherapy	Fuzhou General Hospital	Non-small Cell Lung Cancer	06/24	06/25